Brief: Wilex granted a patent in Europe for the chemical synthesis of dihydroxyisoleucine
28/06/2016 06:30
June 28 (Reuters) - Wilex AG WL6G.DE :
* European patent office grants patent for chemical
synthetic building block dihydroxyisoleucine for production of
Amanitin
* Patent has a term until 2033
Source text for Eikon: ID:nEQ5rjGCRa
Further company coverage: WL6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty